news
South Africa gets first generic semaglutide injection
South Africa saw its first generic semaglutide injection launch in August. More options are coming, which could drop prices for these GLP-1 drugs. The big question is whether this competition will be enough to kill the black market and get drugs to public health patients who need them.
South Africa saw its first generic semaglutide injection launch in August. More options are coming, which could drop prices for these GLP-1 drugs. The big question is whether this competition will be enough to kill the black market and get drugs to public health patients who need them.
The architecture take
The arrival of generic semaglutide in South Africa isn't just about market competition; it's a direct signal about the global future of metabolic health access. When these blockbuster GLP-1 drugs get cheaper, more bodies will get the chance to regulate blood sugar and hormones in new ways. It’s a supply shock that could finally make a dent in the booming black market, which has thrived on desperation and high prices. But it's not a given that lower prices will immediately reach everyone. I'm watching to see if public health systems can absorb these generics fast enough to truly broaden access. This isn't just about weight anymore; it’s about shifting the baseline for how we understand and treat insulin resistance on a massive scale.